| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |